| Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
 | Hazard ratio | 95% CI | p value | Hazard ratio | 95% CI | p value |
Age | 1.02 | 1.02–1.02 |  < 0.001 | 1.02 | 1.02–1.03 |  < 0.001 |
Gender | 1.13 | 1.03–1.24 | 0.009 | 1.31 | 1.19–1.44 |  < 0.001 |
SOFA score | 1.07 | 1.06–1.08 |  < 0.001 | 1.02 | 1–1.03 | 0.080 |
SAPS-II score | 1.02 | 1.02–1.03 |  < 0.001 | 1.01 | 1.01–1.02 |  < 0.001 |
Averaged dynamic mechanical power | 1.04 | 1.03–1.05 |  < 0.001 | 1.06 | 1.05–1.07 |  < 0.001 |
Congestive heart failure | 1.17 | 1.06–1.28 | 0.001 |  |  |  |
Cerebrovascular disease | 1.44 | 1.29–1.59 |  < 0.001 | 1.68 | 1.51–1.87 |  < 0.001 |
Chronic pulmonary disease | 1.04 | 0.94–1.15 | 0.442 |  |  |  |
Diabetes | 1.11 | 0.95–1.28 | 0.181 |  |  |  |
Renal disease | 1.33 | 1.2–1.47 |  < 0.001 |  |  |  |
Malignant cancer | 1.46 | 1.29–1.65 |  < 0.001 | 1.31 | 1.15–1.49 |  < 0.001 |
Severe liver disease | 1.63 | 1.43–1.86 |  < 0.001 | 1.91 | 1.65–2.21 |  < 0.001 |